One paper, also like ours, demonstrated a positive correlation between CXCR6 levels and Gleason scores, reported CXCL16 expression in prostate cancers, and showed increased secretion of CXCL16 from prostate cell lines after treating with TNF-α [47]. The gene discussed is TNF; the disease is prostate carcinoma.